Yes, understood (and I read the detailed PDF after I posted the last message). But you could also say that in 2001 the pfs was 15.9 months and now it is 20.5 months. And the 2001 stats were perhaps a little less than conclusive because they were based on a very small sample size.
I don't think anyone is saying that SIR-Spheres are a new medical breakthrough, as you point out the treatment has been around for some time - but I think these trial results will act as a catalyst for future sales growth. At least the sales force will have something "new" to sell now, even if it is only trial data results!
- Forums
- ASX - By Stock
- SRX
- Ann: SIRFLOX ASCO Abstract Released
Ann: SIRFLOX ASCO Abstract Released, page-25
Featured News
Add SRX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online